Patents Examined by Cary BenZion
  • Methods and compositions in breast cancer diagnosis and therapeutics
    Patent number: 6821732
    Abstract: The present invention is directed to compositions regarding a specific mutation in estrogen receptor alpha and their use as diagnostic markers in breast tissue, such as premalignant lesions, for the development of breast cancer. More specifically, cells of breast cancer whose nucleic acid comprises the estrogen receptor alpha mutation identify the breast cancer to be an invasive breast cancer.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: November 23, 2004
    Inventors: Suzanne Fuqua, Peter O'Connell, D. Craig Allred, Torsten A. Hopp